Clinical trial

Empagliflozin and Sympathetic Nerve Traffic

NCT03254849

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-12-08

PhasePHASE4

Study timeline

Study start (actual)2017-12-08Date precision: day

Registry last updated2020-07-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

EmpagliflozinDRUG · verified · RxNorm: empagliflozin

Hydrochlorothiazide 25 mgDRUG · verified · RxNorm: hydrochlorothiazide 25 MG

Sponsors & collaborators

Profil Institut für Stoffwechselforschung GmbHlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03254849 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.